Showing 20 of 10452 recruiting trials
A Phase II Study of Toripalimab Combined With Sequential Neoadjuvant Chemoradiotherapy in Patients With Esophageal Squamous Cell Carcinoma
Tapinarof for Cutaneous Lupus Erythematosus
LDL-C Optimization Using Inclisiran in Patients in Which Drug-Drug Interactions Limit LDL Lowering
👨⚕️ Michael Wilkinson, MD, University of California, San Diego📍 1 site📅 Started Apr 2025View details ↗
Cannabinoids for the Reduction of Inflammation and Sickle Cell Related Pain
Cannabidiol in Sickle Cell Disease
👨⚕️ Susanna Curtis, Icahn School of Medicine at Mount Sinai📍 1 site📅 Started Apr 2025View details ↗
Golcadomide and Rituximab as Bridging Therapy for Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma Before CAR T-cell Therapy
A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
Epcoritamab Plus Ibrutinib for the Treatment of Relapsed or Refractory Aggressive B-Cell Non-Hodgkin Lymphoma
👨⚕️ Yazeed Sawalha, Ohio State University Comprehensive Cancer Center📍 2 sites📅 Started Apr 2025View details ↗
Evaluation of JSKN016 Combination Therapy in Subjects With NSCLC
Transcorneal Electrical Stimulation for the Treatment of Visual Field Defects in Patients With Open-Angle Glaucoma
👨⚕️ Katrin Lorenz, Prof., Augenklinik und Poliklinik der Universitätsmedizin Mainz, Johannes Gutenberg-Universität Mainz📍 1 site📅 Started Apr 2025View details ↗
G-CSF After Chemo-radiation in Patients With Glioblastoma
MULTIsite Feasibility of MUSIc Therapy to Address Quality Of Life in Sickle Cell Disease
👨⚕️ Jeffery A Dusek, PhD, University of California, Irvine📍 2 sites📅 Started Apr 2025View details ↗
Orelabrutinib Combined With Rituximab ± Lenalidomide in Response-Adapted Stratified Therapy for Untreated MZL
🏥 The First Affiliated Hospital with Nanjing Medical University📍 1 site📅 Started Apr 2025View details ↗
RecruitingNCT07353463 ↗
Shanghai Clinical Cohort - Parkinson's Disease (Reserve)
Tislelizumab , Cyclophosphamide, Mitoxantrone Liposomes, Chidamide, and Prednisone in the Treatment of R/R AITL
Pulsed Electromagnetic Field Treatment With Dementia Patients
RecruitingNCT06997354 ↗
Validation of a Parental Questionnaire for Screening Children for Neurovisual Disorders
Enrolling by InvitationNCT06969586 ↗
The Effect of Topical Rho-kinase Inhibitors on Corneas of Patients With Fuchs Endothelial Corneal Dystrophy
Universal Anti-CD70 CAR-T (CHT101) Cell Therapy for Relapsed Refractory Systemic Lupus Erythematosus
👨⚕️ Lingyun Sun, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School📍 1 site📅 Started Apr 2025View details ↗
CD7 CAR T-Cell Therapy for r/r T-cell Lymphomas
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →